摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

daphneticin

中文名称
——
中文别名
——
英文名称
daphneticin
英文别名
(2R,3R)-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one
daphneticin化学式
CAS
——
化学式
C20H18O8
mdl
——
分子量
386.358
InChiKey
FCWOSPBWIBSFOO-CRAIPNDOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    28
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    104
  • 氢给体数:
    2
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    乙酸酐daphneticin吡啶 作用下, 生成 Acetic acid (2R,3R)-3-(4-acetoxy-3,5-dimethoxy-phenyl)-6-oxo-2,3-dihydro-6H-1,4,5-trioxa-phenanthren-2-ylmethyl ester
    参考文献:
    名称:
    Lin, Lee-Juian; Cordell, Geoffrey A., Journal of Chemical Research, Miniprint, 1988, # 12, p. 3052 - 3080
    摘要:
    DOI:
  • 作为产物:
    描述:
    3,5-二甲氧基-4-羟基肉桂酸吡啶 、 lithium aluminium tetrahydride 、 silver(l) oxide 作用下, 以 甲醇乙醚 为溶剂, 反应 21.0h, 生成 daphneticin
    参考文献:
    名称:
    Lin, Lee-Juian; Cordell, Geoffrey A., Journal of Chemical Research, Miniprint, 1988, # 12, p. 3052 - 3080
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Total synthesis of daphneticin, a coumarinolignoid.
    作者:HITOSHI TANAKA、ICHIRO KATO、KAZUO ITO
    DOI:10.1248/cpb.34.628
    日期:——
    Daphnetin (3) was transformed with excess benzyl chloride into 7, 8-dibenzyloxycoumarin (4), which on treatment with trifluoroacetic acid in benzene or aluminum chloride in benzene gave 8-benzyloxy-7-hydroxycoumarin (5) in good yield. Condensation of 5 and ethyl 2-bromo-3-(4-acetoxy-3, 5-dimethoxyphenyl)-3-oxopropionate (9), prepared from ethyl benzylsyringoylacetate (7) in two steps, in the presence of sodium hydride afforded 10 in good yield, and the condensation product (10) was then reduced with lithium borohydride to yield a mixture of the diols (11a, b). Treatment of the diols with 36% hydrochloric acid in acetic acid provided daphneticin (1) in 68% yield.
    Daphnetin (3) 与过量的氯化苄一起转化为 7,8-二苄氧基香豆素 (4),用苯中的三氟乙酸或苯中的氯化铝处理后得到 8-苄氧基-7-羟基香豆素 (5),收率很高。在氢化钠存在下,将 5 与 2-溴-3-(4-乙酰氧基-3, 5-二甲氧基苯基)-3-氧代丙酸乙酯 (9) (由苄基丁酰基乙酸乙酯 (7) 分两步制备)缩合,得到 10,收率很好,然后用硼氢化锂还原缩合产物 (10),得到二元醇混合物 (11a, b)。然后用硼氢化锂还原缩合产物(10),得到二元醇混合物(11a、b)。用 36% 的盐酸和乙酸处理这些二元醇,得到水飞蓟宾(1),收率为 68%。
  • Tanaka, Hitoshi; Ishihara, Masaya; Ichino, Kazuhiko, Heterocycles, 1987, vol. 26, # 12, p. 3115 - 3122
    作者:Tanaka, Hitoshi、Ishihara, Masaya、Ichino, Kazuhiko、Ito, Kazuo
    DOI:——
    日期:——
  • [EN] THERAPEUTIC RELEASE AGENTS<br/>[FR] AGENTS DE LIBÉRATION THÉRAPEUTIQUES
    申请人:ORGANON NV
    公开号:WO2008100977A2
    公开(公告)日:2008-08-21
    [EN] Pharmacological inhibition of fatty acid amide hydrolase (FAAH) activity leads to increased levels of fatty acid amides. Esters of alkylcarbamic acids are disclosed that are inhibitors of FAAH activity. Compounds disclosed herein inhibit FAAH activity. Described herein are processes for the preparation of esters of alkylcarbamic acid compounds, compositions that include them, and methods of use thereof.
    [FR] L'inhibition pharmacologique de l'activité de l'amide hydrolase d'acides gras (FAAH) entraîne une augmentation des taux d'amides d'acides gras. L'invention concerne des esters d'acides alkylcarbamiques qui constituent des inhibiteurs de l'activité de la FAAH. Les composés décrits inhibent l'activité de la FAAH. L'invention concerne aussi des procédés de préparation d'esters de composés d'acides alkylcarbamiques, des compositions renfermant ceux-ci et des procédés d'utilisation de celles-ci.
  • [EN] SESQUITERPENE LACTONES AS POTENT AND BROAD SPECTRUM ANTIVIRAL COMPOUNDS AGAINST ALL GENOTYPES OF HEPATITIS C VIRUS (HCV)<br/>[FR] LACTONES SESQUITERPÉNIQUES EN TANT QUE COMPOSÉS ANTIVIRAUX PUISSANTS ET À LARGE SPECTRE CONTRE TOUS LES GÉNOTYPES DU VIRUS DE L'HÉPATITE C (VHC)
    申请人:ELSEBAI MAHMOUD FAHMI
    公开号:WO2016169573A1
    公开(公告)日:2016-10-27
    The present invention relates to potent HCV entry inhibitors (cynaropicrin and grosheimol), in addition to mono-caffoeylquinic acid derivatives which have also anti-HCV activity but less than cynaropicrin and grosheimol.
  • Lin, Lee-Juian; Cordell, Geoffrey A., Journal of Chemical Research, Miniprint, 1988, # 12, p. 3052 - 3080
    作者:Lin, Lee-Juian、Cordell, Geoffrey A.
    DOI:——
    日期:——
查看更多

同类化合物

黄花菜木脂素B 瑞香替西 (2S,3S)-daphneticin repenin D cleomiscosin A methyl ether ethyl 3,9-dihydro-3-(4-hydroxy-3-methoxyphenyl)-7-methyl-9-oxo-2H-[1,4]dioxino[2,3-h] chromene-2-carboxylate repenin B ethyl 3,9-dihydro-3-(3,4-dihydroxyphenyl)-7-methyl-9-oxo-2H-[1,4]dioxino[2,3-h]chromene-2-carboxylate repenin C moluccanin molucannin diacetate 8'-epi-cleomiscosin A cleomiscosin A (2S,3S)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-5-methoxy-9H-[1,4]dioxino[2,3-h]chromen-9-one Cleomiscosin D cleomiscosin A monoacetate cleomiscosin D hyosgerin (7′R,8′R)-cleomiscosin C cleomiscosin A diacetate isodaphneticin (3R)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-methoxy-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one 5'-Demethylaquillochin (2R,3R)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-2,3-dihydropyrano[3,2-g][1,4]benzodioxin-7-one cis regioisomer of proparcin regioisoner of proparcin propacin compound-B cleomiscosin A daphneticin cleomiscosin A 6-methoxy-5′′-demethoxydaphneticin [4-[2-(Hydroxymethyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-3-yl]-2-methoxyphenyl] 3-phenylprop-2-enoate 2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-7H-pyrano[2,3-g][1,4]benzodioxin-7-one 2-(Hydroxymethyl)-3-[3-methoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one Cleomiscosin A methyl ether 3-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(8-oxo-[1,3]dioxolo[4,5-h]chromen-2-yl)-2H-pyrano[3,2-h][1,4]benzodioxin-9-one 6-Chloro-3-(4-hydroxy-3-methoxyphenyl)-5-methoxy-2-methyl-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one 2-[3,5-Dimethoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(hydroxymethyl)-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one Cleomiscosin B [3-(4-Hydroxy-3,5-dimethoxyphenyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-2-yl]methyl 3,4-dihydroxybenzoate aquillochin methyl ether 2-(3-Hydroxy-4-methoxyphenyl)-3-methyl-2,3-dihydropyrano[2,3-g][1,4]benzodioxin-7-one 2-(3,4-Dihydroxy-5-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydropyrano[2,3-g][1,4]benzodioxin-7-one [3-(3,4-Dimethoxyphenyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-2-yl]methyl acetate 3-[3,5-Dimethoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2-(hydroxymethyl)-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one [3-(4-Hydroxy-3,5-dimethoxyphenyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-2-yl]methyl acetate [2-Methoxy-4-(5-methoxy-2-methyl-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-3-yl)phenyl] acetate 3-(4-Hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one [3-(4-Hydroxy-3-methoxyphenyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-2-yl]methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate